findmyKOL
Clinical trialNCT03636256CompletedPhase 1/PHASE2Interventional

Evaluation of NanoDoce® in Participants With Urothelial Carcinoma

SponsorNanOlogy, LLCEnrollment36Bladder CancerCancer of the BladderMalignant Tumor of the Urinary BladderUrinary Bladder CancerUrinary Bladder NeoplasmUrogenital Neoplasms+3 more conditions
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a clinical trial studying the administration of NanoDoce as a direct injection to the bladder wall immediately after tumor resection and as an intravesical instillation. All participants will receive NanoDoce, and will be evaluated for safety and tolerability, as well as the potential effects of NanoDoce on urothelial carcinoma.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Bcg Oncology, Pc

    Phoenix, Arizona, United States

  • James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions

    Baltimore, Maryland, United States

  • Columbia University Herbert Irving Comprehensive Cancer Center

    New York, New York, United States

  • Carolina Urologic Research Center

    Myrtle Beach, South Carolina, United States

  • Ut Health San Antonio

    San Antonio, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

NanoDoceNanoDoce - Induction and Maintenance InstillationsNanoDoce - Visit 2 Instillation
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
2 Apr 2019
Primary completion
2 Nov 2021
Completion
2 Nov 2021
Last update posted
14 Aug 2023
Registered enrollment
36
Registry id
NCT03636256
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.